2020 Networking & Komen Scholar Dinner

Featured Presenter:
Dr. Ben Ho Park

“Genetic Alterations as New Targets for Breast Cancer Therapy”

Thank you for joining us for an evening of networking, dinner and an education program presented by Drs. M. Michele Blackwood & Toppmeyer featuring Komen Scholar Dr. Ben Ho Park!

View Photos



Event Details

Monday, February 10 • 5:30 pm – 7 pm

Rutgers Cancer Institute of New Jersey (Auditorium)
195 Little Albany St.
New Brunswick, NJ 08901

Complimentary valet parking will be available for all attendees.


5:30 PM — Networking & Registration

6:00 PM — Welcome from Dr. M. Michele Blackwood

6:15 PM — Presentation by Dr. Ben Ho Park
“Genetic Alterations as New Targets for Breast Cancer Therapy”

6:45 PM — Q&A Led by Dr. Deborah Toppmeyer

Featured Presenter

Dr. Ben Ho Park

Komen Scholar Since 2017
Vanderbilt-Ingram Cancer Center
Nashville, TN

Ben Ho Park, M.D., Ph.D., is the Donna Hall Professor of Medicine at Vanderbilt University Medical Center. He is also Co-Leader of the Breast Cancer Research Program, Associate Director for Translational Research and Director of Precision Oncology for Vanderbilt-Ingram Cancer Center. He received his M.D. and Ph.D. degrees in 1995 at The University of Pennsylvania School of Medicine. Further specializing in Internal Medicine and Hematology/Oncology, he went to Johns Hopkins for a postdoctoral fellowship in cancer genetics, before joining its faculty in 2002. Dr. Park’s research focuses on using genetic models to identify, validate and develop targeted therapies for breast cancer. He specifically studies the PI3 Kinase/AKT signaling pathway and his work identified high frequency of mutation in the PIK3CA gene in human breast cancers, opening the door for PI3K-targeted therapies in breast cancer.

With Komen-funding, Dr. Park is pursuing his efforts in precision oncology: specific drugs to specific patients, focusing on targeting mutations in a gene called SF3B1 that are present only in cancer cells and not normal cells.


Deborah Toppmeyer, MD

Chief Medical Officer
Director, Stacy Goldstein Breast Cancer Center
Rutgers Cancer Institute of New Jersey

M. Michele Blackwood, MD, FACS

Chief, Section of Breast Surgery, Rutgers Cancer Institute of New Jersey and Medical Director, Northern Regional Director of Breast Services, RWJBarnabas Health

2020 Sponsors

< >


If you have any questions, please email info@komencsnj.org.

Go to Top